A 32-year-old man spent 10 days in the hospital after taking daily gas station kratom pills for two years, suffering from septic shock, temporary hearing loss and severe muscle breakdown, according to a medical case report published by the New York Post.
The patient, who had a history of anxiety, sought emergency care after falling in his shower and remaining unconscious for eight hours. Upon arrival at the hospital, he reported a headache, nausea, slurred speech, brief memory loss, right ear pain and hearing loss in his right ear.
Severe Diagnoses and Intensive Treatment
Hospital staff diagnosed the patient with septic shock, an extreme response to an infection that compromises the body’s immune system. The condition stemmed from auriculitis, an infection inside his ear. Doctors also identified rhabdomyolysis, a dangerous medical condition characterized by rapid muscle tissue breakdown that floods the bloodstream with proteins and electrolytes, placing organ function at severe risk.
During his hospital stay, which included three days in intensive care, the patient received multi-faceted medical treatment:
- Targeted antibiotic therapy to eliminate the severe ear infection causing sepsis.
- Intravenous fluid drips to protect organ function and resolve rhabdomyolysis.
- Steroid treatments to address right-ear inflammation and restore his hearing.
Following 10 days of medical intervention, the patient recovered his hearing and was discharged from the facility.
Substance Interactions and Regulatory Efforts
A urine drug screen conducted during admission showed the patient had fentanyl in his system, while testing negative for other illicit substances. Medical professionals indicated that either kratom or fentanyl triggered the rhabdomyolysis. They noted that the heavy sedative effect of the substances likely caused him to lie immobile on the floor for eight hours, initiating muscle damage.
Physicians emphasized that kratom can impede the body’s metabolism of fentanyl, extending the time the synthetic opioid stays active in the system. Combining the two drugs carries severe hazards, including prolonged sedation, respiratory failure and fatal overdose risks. Doctors also noted that electrolyte shifts caused by rhabdomyolysis likely contributed to the temporary hearing loss.
Rhabdomyolysis affects approximately 26,000 people in the U.S. each year. While endurance athletes and young women are frequently cited as vulnerable groups—such as 24-year-old runner Rachel Apa, who died from rhabdomyolysis shortly after competing in the New York City marathon—prolonged immobility from heavy sedation is another recognized trigger.
Kratom is derived from an herbal tree native to Southeast Asia and is widely available at gas stations, vape shops and online outlets. While federally legal, it is not approved by the Food and Drug Administration for medical treatment. Manufacturers frequently market the substance as a natural remedy for anxiety, pain, energy boosting and opioid addiction recovery. However, the leaves contain active psychoactive compounds—mitragynine and 7-hydroxymitragynine—that bind to opioid receptors in the brain. The Drug Enforcement Administration warns that heavy use can cause hallucinations, seizures and death.
Poison control centers nationwide documented a 1,200 percent surge in kratom-related calls between 2021 and 2025. In response to mounting health concerns, Health and Human Services Secretary Robert F. Kennedy Jr. announced last year that federal authorities were working to classify 7-hydroxymitragynine as a Schedule I controlled substance alongside heroin and LSD.



